www.philly.com

www.philly.com
Share

www.philly.com

 •  February 6

Imagine a drug that, a month after a single intravenous dose, wipes out all evidence of leukemia in 80 percent of deathly ill children who receive it. Now, imagine that the drug takes a month to make from each patient’s own immune cells, that many children die waiting, that it causes terrible temporary side effects in some patients, that it costs...

www.philly.com

 •  January 30

TUESDAY, Jan. 30, 2018 (HealthDay News) -- Obesity can change how prescription drugs work, but many medications used to treat children don't say so on their labels, researchers report. Federal lawmakers offered drug manufacturers incentives to study how drugs affect kids, but many have not provided safety guidelines for those who are obese, the...

www.philly.com

 •  January 17

Buy Photo In an effort to help stop a “public health nightmare,” the City of Philadelphia on Wednesday sued several regional pharmaceutical companies, claiming that their marketing methods have been so misleading, they have fueled the city’s opioid crisis. Numerous state and county governments have filed such suits recently, but Philadelphia has...

www.philly.com

 •  January 12

Federal legislation that aims to give desperately ill patients greater access to unapproved drugs reflects a broader effort to weaken medical product regulation, two University of Pennsylvania bioethicists argue in a prominent medical journal. The federal “right to try” bill, which passed the Senate in August, is being pushed by supporters in the...

www.philly.com

 •  December 26, 2017

Renda Bower knows well the cost of drugs to treat rheumatoid arthritis – her husband, son and daughter all have the painful, disabling autoimmune disease. And the family’s finances revolve around paying for them. Even with insurance, Bower’s family last year faced $600 a month in copayments for the drug, plus additional payments on another $16,000...

www.philly.com

 •  September 21, 2017

Delaware County has become the first county in Pennsylvania to sue some of the largest manufacturers of addictive painkillers, joining a growing number of municipalities nationwide that have taken that step with the hope of stemming the deadly opioid epidemic. Delaware County District Attorney Jack Whelan announced the lawsuit Thursday afternoon...

www.philly.com

 •  August 30, 2017

Bensalem plans to sue pharmaceutical manufacturers in hopes of recouping tens of millions of dollars spent fighting and opioid epidemic that officials believe was fueled by greedy drug companies. Township officials said they looked forward to becoming the first jurisdiction in the Philadelphia region to join a small but growing list of states,...

www.philly.com

 •  August 24, 2017

Recent actions by federal and state officials have put opioid manufacturers in the spotlight at a time when drug overdoses are a national crisis. Efforts meant to fight prescription pain medication abuse may be helping company profit margins more than consumers and patients. In July, the Food and Drug Administration (FDA) asked Endo Pharmaceuticals...

www.philly.com

 •  April 4, 2017

A leading Democratic senator is investigating the nation’s top opioid manufacturers to determine whether they contributed to overuse of the painkillers at the center of a deadly addiction crisis that has led to nearly 200,000 overdose deaths in the past 15 years. Sen. Claire McCaskill of Missouri on Mar. 28 asked the manufacturers of the nation’s...

www.philly.com

 •  February 23, 2017

Incyte Corp., a biopharmaceutical firm in Wilmington, announced Thursday a research collaboration with the Abramson Cancer Center at the University of Pennsylvania to come up with new immuno-oncology drugs to treat cancers. Incyte, founded by former employees of DuPont Pharmaceuticals in 2002, will fund the research. Financial terms were not...